In this column for Bioanalysis Zone, BioAgilytix’s Global Chief Scientific Officer, Dr. Afshin Safavi, discusses how applying the concepts of ‘fit-for-purpose’ (FFP) and ‘context of use’ (COU) can help in constructing biomarker assays that adequately meet investigation goals.
Click for full article
Services
Platforms